- Recommendation ID
- NG203/22
- Question
Management of anaemia of CKD with concurrent illness: What is the optimal management (in terms of clinical and cost effectiveness) of anaemia of CKD in people who are receiving erythropoietic stimulating agents (ESAs) and have a significant concurrent acute infectious illness?
- Any explanatory notes
(if applicable)
Source guidance details
- Comes from guidance
- Chronic kidney disease: assessment and management
- Number
- NG203
- Date issued
- August 2021
Other details
| Is this a recommendation for the use of a technology only in the context of research? | No |
| Is it a recommendation that suggests collection of data or the establishment of a register? | No |
| Last Reviewed | 31/08/2021 |